Pulmonary Hypertension and Venous Thromboembolism - Pulmonary Hypertension - 677 · pulmonary-hypertension
    • CardiologyTalk

      Site: CardiologyTalk

    • Quick Links
      • Schedule An Interview
      • What Is Our Interview Process
    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Pulmonary Embolism 1
  • Amyloidosis 10
  • Angina 1
  • Anticoagulation Management 1
  • Aortic Stenosis 1
  • Arrhythmias and Clinical EP 2
  • Atrial Fibrillation 18
  • Autonomic Cardiology 1
  • Blood Pressure 1
  • Cardiac Implantable Electronic Devices 2
  • Cardiac Injury 3
  • Cardiac Surgery 13
  • Cardio-Oncology 17
  • Cardiogenic Shock 4
  • Cardiology 111
  • Cardiology Advocacy 16
  • Cardiomyopathy 5
  • Cardiorenal 2
  • Cardiorenal Syndrome 1
  • Cardiovascular Disease 17
  • Cardiovascular Imaging 2
  • Conference Coverage 63
  • Congenital Heart Disease 1
  • Coronary Artery Disease 11
  • Coronary Microvascular Dysfunction 3
  • Coronary Pharmacotherapy 1
  • Coronary Stent 2
  • COVID-19 81
  • Diabeto-Cardiology 2
  • Dyslipidemia 1
  • Echocardiograms 3
  • Heart Disease 1
  • Heart Failure and Cardiomyopathies 60
  • Heart Transplant 1
  • Heart Valve 3
  • Hemostasis 1
  • Hypertension 12
  • Hypertrophic Cardiomyopathy 2
  • Irregular Heart Rhythm 1
  • Ischemic Heart Disease 4
  • Myocardial Infarction 13
  • Prevention 4
  • Pulmonary Hypertension 2
  • Stroke 1
  • Structural Heart Disease 1
  • TAVR 3
  • Transcatheter Aortic Valve (TAVI) 3
  • Tricuspid Regurgitation 1
  • Valvular Heart Disease 2
  • Vasovagal Syncope 1
  • Ventricular Failure 1
  • Acute Coronary Syndromes 189

  • Install
  • Play a Link
  • About
  • Contact
Podcast- Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis @mgtrivieri #Hypertension #MountSinaiHe...
0:25:52

Podcast- Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F...

Dr. Maria Trivieri works at Mount Sinai as an assistant professor in the cardiology department. Her specialties are cardiology and cardiovascular disease. In this podcast Dr. Trivieri discusses Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis.

https://www.jacc.org/doi/10.1016/j.jcmg.2021.05.023

Abstract \sObjectives
This study looked at whether 18F-FDG uptake in the pulmonary artery (PA) is linked to hypertension and if it correlates with elevated pulmonary pressures.

Background

PET with 18F-fluorodeoxyglucose (FDG) in combination with computed tomography or cardiac magnetic resonance (CMR) has been used to detect inflammation in the systemic circulation's major arteries. The link between pulmonary hypertension and inflammation of the pulmonary system's vasculature is poorly understood (PH).

Methods

18F-FDG uptake in the PA was quantified using the maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR) in a single-center cohort of 175 patients with suspected cardiac sarcoidosis who underwent hybrid thoracic PET/CMR and compared to available results from right heart catheterization (RHC) or transthoracic echocardiography (TTE).

Results

Thirty-three of the individuals had significant 18F-FDG uptake in the PA wall. The mean PA pressure was considerably greater in the group with PA 18F-FDG uptake compared to the group without uptake (34.4 7.2 mm Hg vs 25.6 9.3 mm Hg; P = 0.003), and 9 (90 percent) of patients with PA 18F-FDG uptake had PH when a mean PA pressure limit of 25 mm Hg was adopted (P 0.05). Signs of PH were evident in a substantially higher percentage of patients with PA 18F-FDG uptake in the TTE subgroup (14 [51.9 percent] vs 37 [29.8 percent]; P 0.05). Based on RHC-derived PA pressures, qualitative assessment of 18F-FDG absorption in the PA wall demonstrated a sensitivity of 33% and specificity of 96% for distinguishing patients with PH. SUVmax and TBR in the PA wall were found to be related to PA pressure as measured by RHC and/or TTE.

Conclusions

We show that PET/CMR absorption of 18F-FDG in the PA is linked to PH and that its intensity is related to PA pressure.

37 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Pulmonary Hypertension Description
Pulmonary Hypertension and Venous Thromboembolism

Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis @mgtrivieri #Hypertension #MountSinaiHeart #Card... Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis @mgtrivieri #Hypertension #MountSinaiHeart #Card...
0:25:52
Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F-Fluorode...
FHD
38 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast- Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis @mgtrivieri #Hypertension #MountSinaiHe...
0:25:52
Podcast- Dr. Maria G. Trivieri, MD - Pulmonary Artery 18F...
37 Views
1 year Ago
Cardiology News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

CardiologyTalk Copyright 2020